ntr283-C_2022247EN.01000101-E0284
(283) An example on the organisation of market surveillance is the requirement in Regulations 1223/2009, Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices for Member States to review and assess the functioning of their market surveillance activities. An example on market surveillance activities is the safeguard procedures based on Chapter R5 of Annex I of Decision No 768/2008/EC that is included in a large number of Union harmonisation legislation.
Source: EUR-Lex (Cellar) · retrieved 2026-09-25 · Text as adopted (Official Journal); later amendments are not incorporated in this text.